These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37967856)

  • 21. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.
    Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR
    Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
    Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H
    Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
    [No Abstract]   [Full Text] [Related]  

  • 24. National Cooperative rHu Erythropoietin Study in patients with chronic renal failure--an interim report. The National Cooperative rHu Erythropoietin Study Group.
    Levin NW; Lazarus JM; Nissenson AR
    Am J Kidney Dis; 1993 Aug; 22(2 Suppl 1):3-12. PubMed ID: 8352269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L; Salusky IB; Fine RN
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
    Campos A; Garin EH
    Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of rHuEPO in treatment of uremic anemia prior to end-stage renal disease.
    Koene RA; Frenken LA
    Kidney Int Suppl; 1992 Oct; 38():S142-7. PubMed ID: 1405365
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there material hazard to treatment with intravenous iron?
    Fishbane S; Maesaka JK; Mittal SK
    Nephrol Dial Transplant; 1999 Nov; 14(11):2595-8. PubMed ID: 10534495
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis.
    Maurin N; Fitzner S; Fritz H; Gladziwa U; H agel J; Stefanidis I
    Clin Nephrol; 1995 Mar; 43(3):196-200. PubMed ID: 7774078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter trial of erythropoietin in patients on peritoneal dialysis.
    Nissenson AR; Korbet S; Faber M; Burkart J; Gentile D; Hamburger R; Mattern W; Schreiber M; Swartz R; Van Stone J
    J Am Soc Nephrol; 1995 Jan; 5(7):1517-29. PubMed ID: 7703390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure after three different forms of correction of anemia in hemodialysis.
    Pascual J; Teruel JL; Marcén R; Liaño F; Ortuño J
    Int J Artif Organs; 1992 Jul; 15(7):393-6. PubMed ID: 1516988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model.
    Murphy AM; Xenocostas A; Pakkiri P; Lee TY
    J Neurosurg; 2008 Dec; 109(6):1155-64. PubMed ID: 19035736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease.
    Salvarani C; Lasagni D; Casali B; Macchioni P; Boiardi L; Rossi F; Rivasi P; Portioli I
    J Rheumatol; 1991 Aug; 18(8):1168-71. PubMed ID: 1941817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red cell mass responses to daily erythropoietin and iron injections in the ovine fetus.
    Zhang L; Alexander RL; Widness JA; Cheung CY; Brace RA
    Am J Obstet Gynecol; 2002 Feb; 186(2):315-20. PubMed ID: 11854657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
    Koppensteiner R; Stockenhuber F; Jahn C; Balcke P; Minar E; Ehringer H
    BMJ; 1990 Jun; 300(6740):1626-7. PubMed ID: 2372642
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia.
    Randolph JE; Scarlett J; Stokol T; MacLeod JN
    J Vet Intern Med; 2004; 18(1):81-91. PubMed ID: 14765736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of anemia associated with chronic renal failure by recombinant human erythropoietin treatment in ICR-derived glomerulonephritis (ICGN) mice.
    Yamaguchi-Yamada M; Manabe N; Goto Y; Anan S; Miyamoto K; Miyamoto Y; Nagao M; Yamamoto Y; Ogura A
    J Vet Med Sci; 2004 Jul; 66(7):883-6. PubMed ID: 15297765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute postoperative anemia with recombinant human erythropoietin.
    Levine EA; Rosen AL; Sehgal LR; Gould SA; Egrie JC; Sehgal HL; Moss GS
    J Trauma; 1989 Aug; 29(8):1134-8; discussion 1138-9. PubMed ID: 2760953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.